Accelerate Diagnostics, Inc. (AXDX)

Accelerate Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	25	57	70	342	432	923
Market Cap Growth	-69.25%	-18.47%	-79.57%	-20.78%	-53.19%	48.17%
Enterprise Value	49	83	102	390	514	949
PE Ratio	-	-0.93	-1.12	-4.41	-5.53	-10.95
PS Ratio	2.03	4.73	5.49	29.07	38.72	99.33
PB Ratio	-0.83	-2.87	-3.14	-9.76	-6.88	-125.15
P/FCF Ratio	-0.58	-1.38	-1.42	-7.15	-8.35	-14.18
P/OCF Ratio	-0.61	-1.42	-1.44	-7.24	-8.58	-14.25
EV/Sales Ratio	4.06	6.89	7.99	33.10	46.04	102.09
EV/EBITDA Ratio	-1.00	-1.67	-1.83	-6.54	-8.62	-14.05
EV/EBIT Ratio	-0.93	-1.57	-1.73	-6.28	-8.20	-13.53
EV/FCF Ratio	-1.25	-2.01	-2.07	-8.14	-9.93	-14.57
Debt / Equity Ratio	-1.57	-1.97	-3.48	-3.17	-2.39	-18.17
Debt / EBITDA Ratio	-0.88	-0.79	-1.39	-1.86	-2.51	-1.98
Debt / FCF Ratio	-1.10	-0.95	-1.57	-2.32	-2.90	-2.06
Quick Ratio	1.11	1.32	0.72	9.49	10.02	13.68
Current Ratio	1.50	2.03	0.84	10.56	11.77	14.93
Asset Turnover	0.32	0.28	0.19	0.13	0.10	0.06
Interest Coverage	-5.64	-6.85	-15.59	-4.00	-4.03	-4.92
Return on Equity (ROE)	197.90%	186.30%	166.30%	147.30%	181.40%	-469.60%
Return on Assets (ROA)	-156.10%	-143.70%	-92.60%	-88.60%	-72.30%	-55.10%
Return on Capital (ROIC)	-328.81%	-279.47%	-113.62%	-94.10%	-73.07%	-57.49%
Earnings Yield	-239.11%	-108.03%	-89.32%	-22.69%	-18.09%	-9.13%
FCF Yield	-149.08%	-72.29%	-70.44%	-13.99%	-11.97%	-7.05%
Buyback Yield / Dilution	-95.48%	-51.86%	-33.10%	-10.21%	-2.76%	-0.02%
Total Shareholder Return	-95.48%	-51.86%	-33.10%	-10.21%	-2.76%	-0.02%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).